Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERO
801
DELISTED
CERo Therapeutics
CERO
| $6.68M | ﹤0.01% |
325
-325
| -50% | -$6.62M |
|
802
Takeda Pharmaceutical
TAK
$55.1B
| $6.67M | ﹤0.01% |
427,660
-456,592
| -52% | -$6.38M |
|
803
MP Materials
MP
$7.42B
| $6.61M | ﹤0.01% |
272,051
-24,745
| -8% | -$750K |
|
|
CNTA
804
DELISTED
Centessa Pharmaceuticals
CNTA
| $6.58M | ﹤0.01% |
2,114,519
-3,775,393
| -64% | -$14M |
|
805
GE Aerospace
GE
$368B
| $6.56M | ﹤0.01% |
125,663
-121,438
| -49% | -$5.97M |
|
|
DOC
806
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $6.54M | ﹤0.01% |
452,093
-494,811
| -52% | -$7.19M |
|
807
Invesco QQQ Trust
QQQ
$450B
| $6.53M | ﹤0.01% |
+24,537
| New | +$6.78M |
|
808
Moody's
MCO
$83.5B
| $6.49M | ﹤0.01% |
23,312
-208,808
| -90% | -$57.1M |
|
809
Valero Energy
VLO
$92.6B
| $6.45M | ﹤0.01% |
50,843
-47,649
| -48% | -$5.98M |
|
810
Atmos Energy
ATO
$29.1B
| $6.38M | ﹤0.01% |
56,933
+21,717
| +62% | +$2.39M |
|
811
Wheaton Precious Metals
WPM
$51.5B
| $6.34M | ﹤0.01% |
162,353
-147,317
| -48% | -$5.33M |
|
812
Phillips 66
PSX
$84.4B
| $6.3M | ﹤0.01% |
60,497
-55,575
| -48% | -$5.68M |
|
813
Service Corp International
SCI
$11.7B
| $6.24M | ﹤0.01% |
90,294
-108,716
| -55% | -$7.24M |
|
|
DEN
814
DELISTED
Denbury Inc.
DEN
| $6.22M | ﹤0.01% |
71,481
-102,617
| -59% | -$9.32M |
|
815
Expensify
EXFY
$178M
| $6.22M | ﹤0.01% |
704,112
-703,692
| -50% | -$7.88M |
|
816
CenterPoint Energy
CNP
$27.8B
| $6.1M | ﹤0.01% |
203,531
-354,401
| -64% | -$10.3M |
|
|
PUCK
817
DELISTED
Goal Acquisitions Corp. Common Stock
PUCK
| $6.1M | ﹤0.01% |
606,542
-606,534
| -50% | -$6.03M |
|
|
BWC
818
DELISTED
Blue Whale Acquisition Corp I Class A Ordinary Shares
BWC
| $6.07M | ﹤0.01% |
620,000
+320,000
| +107% | +$3.11M |
|
|
MIT
819
DELISTED
Mason Industrial Technology, Inc.
MIT
| $6.03M | ﹤0.01% |
603,516
-445,524
| -42% | -$4.43M |
|
|
KYNB
820
Kyntra Bio
KYNB
$27.5M
| $6.02M | ﹤0.01% |
15,034
+13,702
| +1,029% | +$5.25M |
|
821
Nasdaq
NDAQ
$53.2B
| $5.99M | ﹤0.01% |
97,567
-81,815
| -46% | -$5.1M |
|
|
LITT
822
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
| $5.98M | ﹤0.01% |
600,218
-400,218
| -40% | -$3.94M |
|
823
SiriusXM
SIRI
$10.4B
| $5.97M | ﹤0.01% |
102,313
-221,289
| -68% | -$13.6M |
|
824
Omnicom Group
OMC
$21.8B
| $5.93M | ﹤0.01% |
72,751
+23,453
| +48% | +$1.74M |
|
|
GRP.U
825
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $5.93M | ﹤0.01% |
116,072
-206,104
| -64% | -$11M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.